Tubulin Carboxypeptidase Activity Promotes Focal Gelatin Degradation in Breast Tumor Cells and Induces Apoptosis in Breast Epithelial Cells That Is Overcome by Oncogenic Signaling.
AuthorMathias, Trevor J
Ju, Julia A
Lee, Rachel M
Thompson, Keyata N
Mull, Makenzy L
Annis, David A
Chang, Katarina T
Ory, Eleanor C
Stemberger, Megan B
Vitolo, Michele I
Martin, Stuart S
MetadataShow full item record
AbstractPost-translational modifications (PTMs) of the microtubule network impart differential functions across normal cell types and their cancerous counterparts. The removal of the C-terminal tyrosine of α-tubulin (deTyr-Tub) as performed by the tubulin carboxypeptidase (TCP) is of particular interest in breast epithelial and breast cancer cells. The recent discovery of the genetic identity of the TCP to be a vasohibin (VASH1/2) coupled with a small vasohibin-binding protein (SVBP) allows for the functional effect of this tubulin PTM to be directly tested for the first time. Our studies revealed the immortalized breast epithelial cell line MCF10A undergoes apoptosis following transfection with TCP constructs, but the addition of oncogenic KRas or Bcl-2/Bcl-xL overexpression prevents subsequent apoptotic induction in the MCF10A background. Functionally, an increase in deTyr-Tub via TCP transfection in MDA-MB-231 and Hs578t breast cancer cells leads to enhanced focal gelatin degradation. Given the elevated deTyr-Tub at invasive tumor fronts and the correlation with poor breast cancer survival, these new discoveries help clarify how the TCP synergizes with oncogene activation, increases focal gelatin degradation, and may correspond to increased tumor cell invasion. These connections could inform more specific microtubule-directed therapies to target deTyr-tubulin.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/18581
- Vasohibins/SVBP are tubulin carboxypeptidases (TCPs) that regulate neuron differentiation.
- Authors: Aillaud C, Bosc C, Peris L, Bosson A, Heemeryck P, Van Dijk J, Le Friec J, Boulan B, Vossier F, Sanman LE, Syed S, Amara N, Couté Y, Lafanechère L, Denarier E, Delphin C, Pelletier L, Humbert S, Bogyo M, Andrieux A, Rogowski K, Moutin MJ
- Issue date: 2017 Dec 15
- Parthenolide and costunolide reduce microtentacles and tumor cell attachment by selectively targeting detyrosinated tubulin independent from NF-κB inhibition.
- Authors: Whipple RA, Vitolo MI, Boggs AE, Charpentier MS, Thompson K, Martin SS
- Issue date: 2013
- Knockout of vasohibin-2 reduces tubulin carboxypeptidase activity and increases paclitaxel sensitivity in ovarian cancer.
- Authors: Koyanagi T, Saga Y, Takahashi Y, Tamura K, Yoshiba T, Takahashi S, Taneichi A, Takei Y, Urabe M, Mizukami H, Fujiwara H
- Issue date: 2021 Apr
- Vasohibin-1 has α-tubulin detyrosinating activity in glomerular podocytes.
- Authors: Mifune T, Tanabe K, Nakashima Y, Tanimura S, Sugiyama H, Sato Y, Wada J
- Issue date: 2022 Apr 9
- Tubulin detyrosination promotes monolayer formation and apical trafficking in epithelial cells.
- Authors: Zink S, Grosse L, Freikamp A, Bänfer S, Müksch F, Jacob R
- Issue date: 2012 Dec 15